Chantal Mathieu is Professor of Medicine at the Katholieke Universiteit and Chair of Endocrinology at the University Hospital Gasthuisberg Leuven, Belgium
She is a physician-scientist who has contributed to the field of diabetes and endocrinology through basic and clinical research. Her basic research work focuses on pathogenesis and prevention of type 1 diabetes. Prof. Mathieu’s clinical work involving new products and treatment paradigms in diabetes, such as new insulins, adjunct therapies and diagnosis of gestational diabetes have made her a speaker in international fora.
Prof. Mathieu coordinates the European project ‘INNODIA’ on biomarker discovery and intervention studies in type 1 diabetes. Prof. Mathieu is president of the European Association for the Study of Diabetes (EASD) and vice-president of the European Diabetes Forum (EUDF).